AU2017261303B9 - Ophthalmic compositions - Google Patents

Ophthalmic compositions Download PDF

Info

Publication number
AU2017261303B9
AU2017261303B9 AU2017261303A AU2017261303A AU2017261303B9 AU 2017261303 B9 AU2017261303 B9 AU 2017261303B9 AU 2017261303 A AU2017261303 A AU 2017261303A AU 2017261303 A AU2017261303 A AU 2017261303A AU 2017261303 B9 AU2017261303 B9 AU 2017261303B9
Authority
AU
Australia
Prior art keywords
ophthalmic composition
chlorhexidine
infection
ophthalmic
eye
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2017261303A
Other languages
English (en)
Other versions
AU2017261303A1 (en
AU2017261303B2 (en
Inventor
Uri SHABTO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sacsh Inc
Original Assignee
Sacsh Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sacsh Inc filed Critical Sacsh Inc
Publication of AU2017261303A1 publication Critical patent/AU2017261303A1/en
Application granted granted Critical
Publication of AU2017261303B2 publication Critical patent/AU2017261303B2/en
Publication of AU2017261303B9 publication Critical patent/AU2017261303B9/en
Assigned to SACSH, INC. reassignment SACSH, INC. Request for Assignment Assignors: SaCSh Corp.
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04—Amoebicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2017261303A 2016-05-06 2017-05-05 Ophthalmic compositions Active AU2017261303B9 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662332789P 2016-05-06 2016-05-06
US62/332,789 2016-05-06
US201662337571P 2016-05-17 2016-05-17
US62/337,571 2016-05-17
PCT/US2017/031211 WO2017192944A1 (en) 2016-05-06 2017-05-05 Ophthalmic compositions

Publications (3)

Publication Number Publication Date
AU2017261303A1 AU2017261303A1 (en) 2018-11-22
AU2017261303B2 AU2017261303B2 (en) 2021-09-16
AU2017261303B9 true AU2017261303B9 (en) 2021-09-23

Family

ID=58709627

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2017261303A Active AU2017261303B9 (en) 2016-05-06 2017-05-05 Ophthalmic compositions

Country Status (10)

Country Link
US (2) US10610499B2 (enExample)
EP (1) EP3452093B1 (enExample)
JP (1) JP6941157B2 (enExample)
CN (1) CN109715215A (enExample)
AU (1) AU2017261303B9 (enExample)
BR (1) BR122024001664A2 (enExample)
CA (1) CA3022983C (enExample)
DK (1) DK3452093T3 (enExample)
TW (1) TWI738774B (enExample)
WO (1) WO2017192944A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3022983C (en) 2016-05-06 2024-05-07 SaCSh Corp. Ophthalmic compositions comprising chlorhexidine and an anti-inflammatory agent
KR102340804B1 (ko) * 2019-07-22 2021-12-17 주식회사 휴온스메디케어 클로르헥시딘 또는 이의 유도체를 포함하는 항균 지속성이 개선된 수용성 소독용 조성물 및 이를 포함하는 섬유형 소독제
MX2022006523A (es) * 2019-12-03 2022-07-01 Ntc S R L Composicion que comprende budesonida para uso oftalmico.
US12357594B1 (en) 2021-06-30 2025-07-15 Sage Products, Llc Antimicrobial solution for pre-operative preparation
US11951087B2 (en) * 2021-07-27 2024-04-09 Lanny Leo Johnson Eye wash compositions and methods
WO2025176750A1 (en) 2024-02-23 2025-08-28 Heinrich-Heine-Universität Düsseldorf Dual targeting in a new class of active ingredients
CN119792261B (zh) * 2025-03-14 2025-07-11 华中科技大学同济医学院附属同济医院 治疗泌尿系感染的抗菌剂及其制备方法和应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0807434A1 (en) * 1995-01-20 1997-11-19 Wakamoto Pharmaceutical Co., Ltd. Anti-inflammatory eyedrops
US20050234018A1 (en) * 2004-04-15 2005-10-20 Allergan, Inc. Drug delivery to the back of the eye
US20100240624A1 (en) * 2009-03-17 2010-09-23 Aciex Therapeutics, Inc. Ophthalmic Formulations of Ketotifen and Methods of Use

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO59572A2 (enExample) 1972-01-29 1976-03-15
JP3781792B2 (ja) * 1993-12-27 2006-05-31 千寿製薬株式会社 ジフルプレドナート含有点眼用懸濁液剤
US5556848A (en) * 1993-12-27 1996-09-17 Senju Pharmaceutical Co., Ltd. Ophthalmic suspension containing diflupredonate
GB9616208D0 (en) * 1996-08-01 1996-09-11 Smithkline Beecham Plc Novel Compounds
US6218428B1 (en) 2000-04-28 2001-04-17 Emil Chynn Ophthalmic composition
US6872705B2 (en) 2001-07-13 2005-03-29 Allergan, Inc. Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions
DE102005046769A1 (de) * 2005-09-29 2007-04-05 Berlin-Chemie Ag Lichtstabile, brivudinhaltige pharmazeutische Formulierung zur Behandlung von Augenherpes (Herpes Ophthalmicus)
WO2009006130A2 (en) 2007-06-28 2009-01-08 Bausch & Lomb Incorporated Salt free hyaluronate ophthalmic solution
US9017725B2 (en) 2009-06-09 2015-04-28 Aurinia Pharmaceuticals Inc. Topical drug delivery systems for ophthalmic use
US20130165419A1 (en) 2011-12-21 2013-06-27 Insite Vision Incorporated Combination anti-inflammatory ophthalmic compositions
CN102973925A (zh) * 2012-11-27 2013-03-20 顾月燕 一种促进伤口愈合的组合物的制备方法
CN105979940A (zh) * 2013-12-12 2016-09-28 创新技术股份有限公司 控制感染的材料和方法
CA3022983C (en) 2016-05-06 2024-05-07 SaCSh Corp. Ophthalmic compositions comprising chlorhexidine and an anti-inflammatory agent

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0807434A1 (en) * 1995-01-20 1997-11-19 Wakamoto Pharmaceutical Co., Ltd. Anti-inflammatory eyedrops
US20050234018A1 (en) * 2004-04-15 2005-10-20 Allergan, Inc. Drug delivery to the back of the eye
US20100240624A1 (en) * 2009-03-17 2010-09-23 Aciex Therapeutics, Inc. Ophthalmic Formulations of Ketotifen and Methods of Use

Also Published As

Publication number Publication date
EP3452093A1 (en) 2019-03-13
AU2017261303A1 (en) 2018-11-22
CN109715215A (zh) 2019-05-03
DK3452093T3 (da) 2021-06-28
CA3022983C (en) 2024-05-07
AU2017261303B2 (en) 2021-09-16
WO2017192944A1 (en) 2017-11-09
TWI738774B (zh) 2021-09-11
JP2019515040A (ja) 2019-06-06
BR122024001664A2 (pt) 2024-02-27
EP3452093B1 (en) 2021-04-28
US20170319515A1 (en) 2017-11-09
US20180147162A1 (en) 2018-05-31
CA3022983A1 (en) 2017-11-09
TW201740928A (zh) 2017-12-01
US10632083B2 (en) 2020-04-28
JP6941157B2 (ja) 2021-09-29
BR112018072647A2 (pt) 2019-02-19
US10610499B2 (en) 2020-04-07

Similar Documents

Publication Publication Date Title
AU2017261303B9 (en) Ophthalmic compositions
TWI677343B (zh) 含有普維酮-碘之眼用組成物
US20220071924A1 (en) Treatment of ocular diseases with ophthalmic tapinarof compositions
BR112018072647B1 (pt) Composições oftálmicas
US20210290527A1 (en) Compositions and Methods for Treatment of Ocular Conditions
HK1130665A (en) Ophthalmic compositions comprising povidone-iodine
HK1192720B (en) Ophthalmic compositions comprising providone-iodine
HK1192720A (zh) 包含聚维酮碘的眼用组合物
HK1130665B (zh) 包含聚维酮碘的眼用组合物

Legal Events

Date Code Title Description
SREP Specification republished
FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: SACSH, INC.

Free format text: FORMER OWNER(S): SACSH CORP.